Genflow Biosciences (LON:GENF) Releases Earnings Results

Genflow Biosciences (LON:GENF) issued its earnings results on Thursday. The company reported GBX (0.33) earnings per share for the quarter, Digital Look Earnings reports. Genflow Biosciences had a return on equity of 377.33% and a net margin of 840.76%.

Genflow Biosciences Stock Performance

Shares of LON:GENF opened at GBX 2.63 on Friday. The firm has a fifty day moving average price of GBX 2.06 and a 200 day moving average price of GBX 1.98. Genflow Biosciences has a fifty-two week low of GBX 0.55 and a fifty-two week high of GBX 3.12. The firm has a market cap of £14.06 million, a price-to-earnings ratio of -5.23 and a beta of 2.11.

Genflow Biosciences Company Profile

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.